Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8517507rdf:typepubmed:Citationlld:pubmed
pubmed-article:8517507lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8517507lifeskim:mentionsumls-concept:C0002556lld:lifeskim
pubmed-article:8517507lifeskim:mentionsumls-concept:C0221423lld:lifeskim
pubmed-article:8517507lifeskim:mentionsumls-concept:C0010340lld:lifeskim
pubmed-article:8517507lifeskim:mentionsumls-concept:C0439793lld:lifeskim
pubmed-article:8517507lifeskim:mentionsumls-concept:C0683148lld:lifeskim
pubmed-article:8517507pubmed:issue2lld:pubmed
pubmed-article:8517507pubmed:dateCreated1993-7-22lld:pubmed
pubmed-article:8517507pubmed:abstractTextThe volume of distribution of amikacin and the APACHE II score were determined in 42 critically ill patients being treated for a gram-negative infection. The mean volume of distribution (Vdt) was 0.41 +/- 0.12 l/kg with a wide range (normal of 0.25 l/kg). There was a good relationship between the Vdt and illness severity as measured by the APACHE II score (r = 0.70; P < 0.001). Critically ill patients should receive larger loading doses of aminoglycosides in order to achieve therapeutic blood levels. The aminoglycoside Vdt may be useful in determining the degree of capillary leak and tissue oedema that accompanies sepsis.lld:pubmed
pubmed-article:8517507pubmed:languageenglld:pubmed
pubmed-article:8517507pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8517507pubmed:citationSubsetIMlld:pubmed
pubmed-article:8517507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8517507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8517507pubmed:statusMEDLINElld:pubmed
pubmed-article:8517507pubmed:monthAprlld:pubmed
pubmed-article:8517507pubmed:issn0310-057Xlld:pubmed
pubmed-article:8517507pubmed:authorpubmed-author:MarikP EPElld:pubmed
pubmed-article:8517507pubmed:issnTypePrintlld:pubmed
pubmed-article:8517507pubmed:volume21lld:pubmed
pubmed-article:8517507pubmed:ownerNLMlld:pubmed
pubmed-article:8517507pubmed:authorsCompleteYlld:pubmed
pubmed-article:8517507pubmed:pagination172-3lld:pubmed
pubmed-article:8517507pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8517507pubmed:meshHeadingpubmed-meshheading:8517507-...lld:pubmed
pubmed-article:8517507pubmed:meshHeadingpubmed-meshheading:8517507-...lld:pubmed
pubmed-article:8517507pubmed:meshHeadingpubmed-meshheading:8517507-...lld:pubmed
pubmed-article:8517507pubmed:meshHeadingpubmed-meshheading:8517507-...lld:pubmed
pubmed-article:8517507pubmed:meshHeadingpubmed-meshheading:8517507-...lld:pubmed
pubmed-article:8517507pubmed:meshHeadingpubmed-meshheading:8517507-...lld:pubmed
pubmed-article:8517507pubmed:meshHeadingpubmed-meshheading:8517507-...lld:pubmed
pubmed-article:8517507pubmed:meshHeadingpubmed-meshheading:8517507-...lld:pubmed
pubmed-article:8517507pubmed:meshHeadingpubmed-meshheading:8517507-...lld:pubmed
pubmed-article:8517507pubmed:year1993lld:pubmed
pubmed-article:8517507pubmed:articleTitleAminoglycoside volume of distribution and illness severity in critically ill septic patients.lld:pubmed
pubmed-article:8517507pubmed:affiliationIntensive Care Unit, Baragwanath Hospital, Soweto, South Africa.lld:pubmed
pubmed-article:8517507pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8517507lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8517507lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8517507lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8517507lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8517507lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8517507lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8517507lld:pubmed